APA (7th ed.) Citation

F, R., MA, N., M, P. K., & SH, A. (2026). Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis. Journal of the neurological sciences, 480, 125693. https://doi.org/10.1016/j.jns.2025.125693

Chicago Style (17th ed.) Citation

F, Rangani, Nahayati MA, Pahlevan Kakhki M, and Aghaee-Bakhtiari SH. "Ocrelizumab Modulates the IL-2 Signaling Pathway and Associated LncRNAs in Multiple Sclerosis." Journal of the Neurological Sciences 480 (2026): 125693. https://doi.org/10.1016/j.jns.2025.125693.

MLA (9th ed.) Citation

F, Rangani, et al. "Ocrelizumab Modulates the IL-2 Signaling Pathway and Associated LncRNAs in Multiple Sclerosis." Journal of the Neurological Sciences, vol. 480, 2026, p. 125693, https://doi.org/10.1016/j.jns.2025.125693.